ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,955Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 444

$543K Total Retail Price of All Prescriptions

Rank: 48 out of 444

1,395 Patients Receiving at Least One Drug in Part D
85% Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nevada
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 1,395 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 1,395 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

8 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 480 421 224 1 1
LEVOTHYROXINE SODIUM 463 405 210 2 2
OMEPRAZOLE 407 358 185 3 5
SIMVASTATIN 403 372 198 4 3
LOVASTATIN 251 215 117 5 15
GABAPENTIN 237 192 99 6 11
ATORVASTATIN CALCIUM 236 201 98 7 8
AMLODIPINE BESYLATE 227 211 106 8 6
TRAMADOL HCL 225 187 124 9 28
HYDROCODONE-ACETAMINOPHEN 221 167 101 S3 10 4
LOSARTAN POTASSIUM 208 194 89 11 9
METFORMIN HCL 207 194 91 12 7
FUROSEMIDE 196 180 88 13 12
VENTOLIN HFA 188 146 119 14 34
HYDROCHLOROTHIAZIDE 178 167 86 15 10
ALENDRONATE SODIUM 175 162 65 16 18
ALPRAZOLAM 150 111 61 B 17 13
ZOLPIDEM TARTRATE 143 112 60 18 19
METOPROLOL TARTRATE 143 126 67 18 14
SERTRALINE HCL 131 103 60 20 31
ATENOLOL 129 117 62 21 17
TRAZODONE HCL 120 89 66 22 32
FLUTICASONE PROPIONATE 119 114* 77 23 27
CITALOPRAM HBR 119 102 52 23 25
PRAVASTATIN SODIUM 111 95 55 25 16
METOPROLOL SUCCINATE 111 97 47 25 20
CIPROFLOXACIN HCL 105 93 84 27 56
POTASSIUM CHLORIDE 95 80 49 28 21
CLOPIDOGREL 89 84* 38 29 24
WARFARIN SODIUM 87 82* 37 30 22
PANTOPRAZOLE SODIUM 81 76* 36 31 44
AZITHROMYCIN 81 62 64 31 43
ALLOPURINOL 81 69 42 31 30
TRIAMCINOLONE ACETONIDE 79 74* 53 34 86
PREDNISONE 74 59 34 35 40
TAMSULOSIN HCL 74 69* 30 35 29
ADVAIR DISKUS 73 54 36 37 49
DONEPEZIL HCL 71 66* 31 38 38
TERAZOSIN HCL 69 69 26 39 46
BACLOFEN 67 62* 41 40 75
ROPINIROLE HCL 66 61* 26 41 104
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 60* 35 42 23
GLIPIZIDE 64 52 27 43 33
SYMBICORT 64 52 35 43 98
GLIPIZIDE ER 61 61 23 45 61
CARVEDILOL 59 54* 28 46 26
METFORMIN HCL ER 58 36 21 47 52
SPIRIVA 58 53* 27 47 41
RANITIDINE HCL 56 42 27 49 36
FLUOXETINE HCL 55 50* 23 50 39
BUPROPION HCL SR 55 50* 21 50 148
TEMAZEPAM 55 39 25 B 50 42
GEMFIBROZIL 52 47* 28 53 71
LORAZEPAM 51 39 29 B 54 48
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 25, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.